All treatments
Treatment
Matching Placebo tablets without active substance clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
283PD201 (LUMA): A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to determine the efficacy and safety of BIIB122 in participants with Parkinson’s Disease
This study is looking into a new medication called BIIB122 for Parkinson's disease. We want to see if it helps slow down the disease's effects on movement and daily activities, compared to a dummy pill. It's an important step in finding new ways to manage Parkinson's.
For: Parkinson's DiseaseFrance · Germany · Austria - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase IIa, randomised, double-blind, placebo-controlled trial to evaluate the safety, efficacy, pharmacokinetics and pharmacodynamics of BI 706321 orally administered for 12 weeks in patients with Crohn`s Disease (CD) receiving ustekinumab induction treatment
This study is looking into a new medication (BI 706321) for Crohn's disease. It aims to see if it's safe and effective when taken alongside an existing treatment called Stelara, and how it works in the body.
For: Crohn`s Disease (CD)Italy · Spain · Czechia